Moreover, intermittent hypoxia in patients with OSA can enhance the release of inflammatory mediators such as tumor necrosis factor-κB, interleukin (IL)-6, and IL-1β, which can lead to a systemic inflammatory response [11]. Here, IL6 is linked to obstructive sleep apnea syndrome.